Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-CA 19-9-Conjugated Fluorophore-Reference-Cited by-同舟云学术

Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-CA 19-9-Conjugated Fluorophore

Published:2014-12-02 Issue:12 Volume:9 Page:e114310
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hiroshima Yukihiko,Maawy Ali,Zhang Yong,Murakami Takashi,Momiyama Masashi,Mori Ryutaro,Matsuyama Ryusei,Katz Matthew H. G.,Fleming Jason B.,Chishima Takashi,Tanaka Kuniya,Ichikawa Yasushi,Endo Itaru,Hoffman Robert M.,Bouvet Michael

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference23 articles.

1. Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival;K Kato;Pancreas,2009

2. Glowing tumors make for better detection and resection;M Bouvet;Sci Transl Med,2011

3. Putting numbers to fluorescent guided surgery;EL Rosenthal;Mol Imaging Biol,2013

4. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer;S Kaushal;J Gastrointest Surg,2008

5. Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation;M McElroy;World J Surg,2008

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting mucins for fluorescence-guided surgery of pancreatic cancer;Molecular-Guided Surgery: Molecules, Devices, and Applications X;2024-03-13

2. Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer;Cancer Letters;2023-05

3. Review: Precise sarcoma patient-derived orthotopic xenograft (PDOX) mouse models enable identification of novel effective combination therapies with the cyclin-dependent kinase inhibitor palbociclib: A strategy for clinical application;Frontiers in Oncology;2022-08-08

4. Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study;Journal of Nuclear Medicine;2022-06-09

5. Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft;In Vivo;2021-12-30